ARWR
☆
EPS:
-0.93
Rev:
74M
Net Inc:
-133M
💾
💾
💾
💾
💾
Income Statement
Balance Sheet
Cash Flow
Revenue
vs Industry
Valuation
Overview
Income Statement
💾
Expenses
💾
Assets
💾
Assets (Current)
💾
Assets (Non-Current)
💾
Liabilities
💾
Liabilities (Current)
💾
Liabilities (Non-Current)
💾
Cash Flow
💾
Cash Flow Investing
💾
Dimension Breakdowns
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
srt:MajorCustomersAxis
Leaf Members
💾
srt:CounterpartyNameAxis, us-gaap:TypeOfArrangementAxis
Leaf Members
💾
ARWR vs
Biotechnology
(37 peers) - Healthcare
Operating Margin
27.6%
-9.0pp vs peers
Net Margin
18.5%
-11.4pp vs peers
Operating Margin
Net Margin
💾
Dimension Breakdowns
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
Leaf Members
💾
Related:
REGN
INCY
VRTX
CPRX
UTHR
ALKS
JAZZ
MRNA
PTCT
APLS